Aigh Capital Management LLC Eagle Pharmaceuticals, Inc. Transaction History
Aigh Capital Management LLC
- $276 Million
- Q2 2024
A detailed history of Aigh Capital Management LLC transactions in Eagle Pharmaceuticals, Inc. stock. As of the latest transaction made, Aigh Capital Management LLC holds 1,211,509 shares of EGRX stock, worth $4.79 Million. This represents 2.46% of its overall portfolio holdings.
Number of Shares
1,211,509
Previous 1,186,509
2.11%
Holding current value
$4.79 Million
Previous $6.22 Million
9.12%
% of portfolio
2.46%
Previous 2.51%
Shares
2 transactions
Others Institutions Holding EGRX
# of Institutions
79Shares Held
9.89MCall Options Held
1.01MPut Options Held
0-
Nantahala Capital Management, LLC New Canaan, CT1.96MShares$7.75 Million0.73% of portfolio
-
Citigroup Inc1MShares$3.96 Million0.0% of portfolio
-
Aqr Capital Management LLC Greenwich, CT697KShares$2.75 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA564KShares$2.23 Million0.0% of portfolio
-
Black Rock Inc. New York, NY353KShares$1.39 Million0.0% of portfolio
About EAGLE PHARMACEUTICALS, INC.
- Ticker EGRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 13,015,900
- Market Cap $51.4M
- Description
- Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...